Vercali Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 09-07-2024
- Paid Up Capital ₹ 0.90 M
as on 09-07-2024
- Company Age 5 Year, 8 Months
- Last Filing with ROC 31 Mar 2021
About Vercali Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.90 M, as per Ministry of Corporate Affairs (MCA) records.
Hemalatha Cherukuneedi and Uday Cherukuneedi serve as directors at the Company.
- CIN/LLPIN
U24239TG2019PTC131713
- Company No.
131713
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Mar 2019
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Vercali Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Uday Cherukuneedi  | Additional Director | 25-Aug-2022 | Current |
| Hemalatha Cherukuneedi | Director | 29-Mar-2019 | Current |
Financial Performance of Vercali Pharma.
Vercali Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Vercali Pharma?
Unlock access to Vercali Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Uday Aqua Connects Private LimitedActive 5 years 1 monthHemalatha Cherukuneedi and Uday Cherukuneedi are mutual person
Kolleru Aqua Diagnostic & Research Lab Private LimitedActive 5 years 6 monthsHemalatha Cherukuneedi and Uday Cherukuneedi are mutual person
Bioaaa It Private LimitedActive 5 years 3 daysHemalatha Cherukuneedi and Uday Cherukuneedi are mutual person
- Cherukuneedi FoundationActive 1 year 5 months
Hemalatha Cherukuneedi and Uday Cherukuneedi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vercali Pharma?
Unlock and access historical data on people associated with Vercali Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vercali Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vercali Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
